Open an account

Danaher

DHR · NYSE

$224.24−$0.19 (−0.08%)TodayMarket closed ·
Prev close $224.43

About DHR

Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. The firm operates through three segments: Biotechnology, Life Sciences and Diagnostics. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a range of equipment, consumables and services that are primarily used by customers to advance and accelerate the research, development, manufacture and delivery of biological medicines. The Life Sciences segment offers a broad range of instruments, consumables, services and software that are primarily used by customers to study the basic building blocks of life, including deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), nucleic acid, proteins, metabolites and cells. The Diagnostics segment offers clinical instruments, consumables, software and services that hospitals, physicians' offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions.

Employees
58,000
Headquarters
WASHINGTON, Washington Dc
Listed
Dec 10, 1969
Sector
Health Care
Industry
Life Sciences Tools & Services
Website
danaher.com

DHR key statistics

Market cap
157.77B
Price-earnings ratio
39.86
Dividend yield
0.61%
Average volume
4.36M
Volume
7.06M
Open price
$225.75
High today
$227.78
Low today
$222.65
52 Week high
$242.80
52 Week low
$160.93

Danaher (DHR) at a glance

As of Oct 20, 2026, Danaher (DHR) shares are priced at $224.24, giving the company a market cap of 157.77B, a price-to-earnings ratio of 39.86 and a dividend yield of 0.61%.

Today the stock has traded between $222.65 and $227.78. The current price is 0.7% above the day's low and 1.6% below its high.

Volume so far is 7.06M shares, above the average of 4.36M shares a day.

Over the past year Danaher has ranged from $160.93 to $242.80, and now sits 77% of the way up that range.

Danaher met or beat analyst EPS estimates in 7 of the last 8 quarters. In Q2 FY26 it reported $1.94 per share against an estimate of $1.85.

The average analyst price target is $234.76, 4.7% above the current price, from 15 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

80%of 15 analyst ratings say Buy
  • Buy80.0%
  • Hold20.0%
  • Sell0.0%
Price target · 25 analystsAvg $234.76
Low
$202.00
Now
$224.24
High
$325.50

DHR earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 7 of the last 8 quarters, by 7.3% on average.

  1. Q3 FY24: reported $1.71 per share against an estimate of $1.58
  2. Q4 FY24: reported $2.14 per share against an estimate of $2.18
  3. Q1 FY25: reported $1.88 per share against an estimate of $1.66
  4. Q2 FY25: reported $1.80 per share against an estimate of $1.66
  5. Q3 FY25: reported $1.89 per share against an estimate of $1.74
  6. Q4 FY25: reported $2.23 per share against an estimate of $2.17
  7. Q1 FY26: reported $2.06 per share against an estimate of $1.96
  8. Q2 FY26: reported $1.94 per share against an estimate of $1.85

DHR news

  • Kaustubh Bagalkote

    Meta Platforms, Tesla Could Swing More Than $100 Billion After Earnings

  • Kaustubh Bagalkote

    Lam Research Could Swing $28.6 Billion After Earnings

  • Akanksha Bakshi

    Danaher Brings NVIDIA AI Into Scientific Instruments in Push for Faster Discoveries

  • Neeraj Jain

    What's Going On With NVIDIA Stock Wednesday?

  • Press releasePRNewswire

    Danaher Collaborates with NVIDIA to Advance Autonomous Science

  • Press releasePRNewswire

    Danaher Announces Appointments of Daniel Comas and Robert Hershberg to Board of Directors

  • Press releasePRNewswire

    Danaher Accelerates Life Sciences Research with New AI-powered Autonomous Lab

  • Press releasePRNewswire

    Julie Sawyer Montgomery Assumes Role as Danaher President and Chief Executive Officer

Similar companies

Companies in the same industry as Danaher

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.